{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:39:03Z","timestamp":1790087943924,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Limited information exists about outcomes of HLA donor-specific antibody (DSA) negative (DSA\u2212) microvascular inflammation (MVI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We report our experience with 25 DSA\u2212 patients with MVI compared to 155 DSA+ patients who met Banff 2013 criteria for antibody-mediated rejection (AMR). We also compared outcomes to 228 DSA+ patients whose biopsies were negative for rejection and served as a negative control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>There were no significant differences in the baseline characteristics between the DSA\u2212 MVI and DSA+ AMR groups. At the time of diagnosis, both groups had similar graft function. The DSA\u2212 group had higher MVI scores but lower C4d scores. At last follow-up, renal function was similar between the groups. There were 12 (48%) graft failures in the DSA\u2212 group and 59 (38%) graft failures in the DSA+ group, which was not statistically different. Similar results were found after matching for the MVI scores, C4d, and treatment between 2 groups. We also found similar outcomes between DSA\u2212 and DSA+ patients when only including those who would have met Banff 2017 criteria for AMR. In univariate Cox regression analyses, estimated glomerular filtration rate at time of biopsy, glomerulitis, rituximab, diabetes, v score, allograft glomerulopathy, fibrous intimal thickening, tubular atrophy, and interstitial fibrosis scores were associated with graft failure. In multivariate analysis, only estimated glomerular filtration rate was protective. Both groups had significantly worse outcomes than the DSA+-negative controls without AMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our findings suggest that outcomes and response to treatment with HLA DSA\u2212 MVI patients are similarly poor to those with DSA+ MVI patients, supporting a critical role for MVI in the diagnosis of AMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002487","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T20:29:34Z","timestamp":1539894574000},"page":"1468-1476","source":"Crossref","is-referenced-by-count":38,"title":["Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"Sandesh","family":"Parajuli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Redfield","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Aziz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad C.","family":"Astor","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier A.","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R3-20231002","article-title":"Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: diagnostic misinterpretation has potential therapeutic implications.","author":"Schinstock","year":"2018","journal-title":"Am J Transplant"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA single antigen bead assays.","volume":"27","author":"Ellis","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies.","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/TXD.0000000000000746","article-title":"Rituximab and monitoring strategies for late antibody-mediated rejection after kidney transplantation.","volume":"3","author":"Parajuli","year":"2017","journal-title":"Transplant Direct"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5500\/wjt.v4.i1.1","article-title":"Impact of donor-specific antibodies on the outcomes of kidney graft: pathophysiology, clinical, therapy.","volume":"4","author":"Salvadori","year":"2014","journal-title":"World J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1600-6143.2003.00021.x","article-title":"Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis.","volume":"3","author":"Le Bas-Bernardet","year":"2003","journal-title":"Am J Transplant"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0b013e31821b60e9","article-title":"Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood.","volume":"92","author":"Jackson","year":"2011","journal-title":"Transplantation"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/gfv375","article-title":"The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.","volume":"32","author":"Lee","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00467-015-3123-5","article-title":"Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.","volume":"30","author":"Pearl","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trre.2017.08.005","article-title":"Defining the phenotype of antibody-mediated rejection in kidney transplantation: advances in diagnosis of antibody injury.","volume":"31","author":"Garg","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ajt.13434","article-title":"Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantation.","volume":"16","author":"Orandi","year":"2016","journal-title":"Am J Transplant"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"R17-20231002","article-title":"Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome.","author":"Senev","year":"2008","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/tri.13154","article-title":"Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome\u2014a retrospective study.","volume":"31","author":"Sablik","year":"2018","journal-title":"Transpl Int"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2015.276","article-title":"Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.","volume":"89","author":"Gupta","year":"2016","journal-title":"Kidney Int"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1600-6143.2011.03931.x","article-title":"A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.","volume":"12","author":"Sis","year":"2012","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:42:42Z","timestamp":1775248962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002487","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}